FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890613092> ?p ?o ?g. }

• W2890613092 endingPage "847" @default.
• W2890613092 startingPage "837" @default.
• W2890613092 abstract "Background/Aims: Previous studies on the effect of metformin therapy on survival of pancreatic cancer patients obtained inconsistent findings. To reevaluate the prognostic value of metformin adjuvant treatment, a meta-analysis was carried out. Methods: Relevant articles addressing the association between metformin use and pancreatic cancer survival were electronically searched to identify eligible studies. Pooled hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated to assess the strength of the association. Results: Totally, seventeen studies involving 36791 participants were included. Overall, metformin use was found to be significantly associated with a favorable OS (HR=0.88, 95% CI=0.80-0.97). Subgroup analyses by ethnicity showed a significantly reduced risk of death for metformin users compared with non-users in Asians (HR=0.74, 95% CI=0.58-0.94) but nonsignificant in Caucasians. When stratified by clinical stage, a remarkable reduction of mortality risk in patients at stage I-II treated with metformin (HR=0.76, 95% CI=0.68-0.86) was found as well as the group at stage I-IV (HR=0.88, 95% CI=0.79-0.99), but not in patients at stage III-IV. In the stratification analyses based on treatment strategy, metformin therapy was found to be associated with a better clinical outcome in patients receiving surgery or comprehensive therapy (HR=0.73, 95% CI=0.62-0.87; HR=0.88, 95% CI=0.79-0.97) but not chemotherapy. However, the overall analysis failed to show a significant association between metformin use and DFS (HR=1.54, 95% CI=0.94 -2.50) with only 2 studies enrolled. Conclusion: The current study has evidenced a significant association of metformin adjuvant treatment with the survival benefit for pancreatic cancer patients, suggesting a potentially available option for the treatment. Further investigation is needed." @default.
• W2890613092 created "2018-09-27" @default.
• W2890613092 creator A5032447166 @default.
• W2890613092 creator A5035064408 @default.
• W2890613092 creator A5035961866 @default.
• W2890613092 creator A5050580197 @default.
• W2890613092 creator A5060220713 @default.
• W2890613092 creator A5062619881 @default.
• W2890613092 creator A5077165659 @default.
• W2890613092 creator A5089285560 @default.
• W2890613092 date "2018-01-01" @default.
• W2890613092 modified "2023-10-17" @default.
• W2890613092 title "Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis" @default.
• W2890613092 cites W1970637701 @default.
• W2890613092 cites W1976655891 @default.
• W2890613092 cites W2000396770 @default.
• W2890613092 cites W2010450183 @default.
• W2890613092 cites W2013047715 @default.
• W2890613092 cites W2033381611 @default.
• W2890613092 cites W2040928783 @default.
• W2890613092 cites W2042198997 @default.
• W2890613092 cites W2051478811 @default.
• W2890613092 cites W2058725063 @default.
• W2890613092 cites W2061731036 @default.
• W2890613092 cites W2068753267 @default.
• W2890613092 cites W2075642745 @default.
• W2890613092 cites W2078190084 @default.
• W2890613092 cites W2088095316 @default.
• W2890613092 cites W2112197935 @default.
• W2890613092 cites W2116475791 @default.
• W2890613092 cites W2122219788 @default.
• W2890613092 cites W2144399303 @default.
• W2890613092 cites W2147297736 @default.
• W2890613092 cites W2153980878 @default.
• W2890613092 cites W2155146717 @default.
• W2890613092 cites W2160391606 @default.
• W2890613092 cites W2160695284 @default.
• W2890613092 cites W2167195670 @default.
• W2890613092 cites W2192618281 @default.
• W2890613092 cites W2198548801 @default.
• W2890613092 cites W2201606479 @default.
• W2890613092 cites W2293940620 @default.
• W2890613092 cites W2340406257 @default.
• W2890613092 cites W2344995542 @default.
• W2890613092 cites W2346224970 @default.
• W2890613092 cites W2410073860 @default.
• W2890613092 cites W2477268183 @default.
• W2890613092 cites W2524637936 @default.
• W2890613092 cites W2570411573 @default.
• W2890613092 cites W2589747936 @default.
• W2890613092 cites W2607424254 @default.
• W2890613092 cites W2611971185 @default.
• W2890613092 cites W2619934750 @default.
• W2890613092 cites W2625337046 @default.
• W2890613092 cites W2735543116 @default.
• W2890613092 doi "https://doi.org/10.1159/000493214" @default.
• W2890613092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30184547" @default.
• W2890613092 hasPublicationYear "2018" @default.
• W2890613092 type Work @default.
• W2890613092 sameAs 2890613092 @default.
• W2890613092 citedByCount "41" @default.
• W2890613092 countsByYear W28906130922019 @default.
• W2890613092 countsByYear W28906130922020 @default.
• W2890613092 countsByYear W28906130922021 @default.
• W2890613092 countsByYear W28906130922022 @default.
• W2890613092 countsByYear W28906130922023 @default.
• W2890613092 crossrefType "journal-article" @default.
• W2890613092 hasAuthorship W2890613092A5032447166 @default.
• W2890613092 hasAuthorship W2890613092A5035064408 @default.
• W2890613092 hasAuthorship W2890613092A5035961866 @default.
• W2890613092 hasAuthorship W2890613092A5050580197 @default.
• W2890613092 hasAuthorship W2890613092A5060220713 @default.
• W2890613092 hasAuthorship W2890613092A5062619881 @default.
• W2890613092 hasAuthorship W2890613092A5077165659 @default.
• W2890613092 hasAuthorship W2890613092A5089285560 @default.
• W2890613092 hasBestOaLocation W28906130921 @default.
• W2890613092 hasConcept C121608353 @default.
• W2890613092 hasConcept C126322002 @default.
• W2890613092 hasConcept C143998085 @default.
• W2890613092 hasConcept C146357865 @default.
• W2890613092 hasConcept C151730666 @default.
• W2890613092 hasConcept C187960798 @default.
• W2890613092 hasConcept C207103383 @default.
• W2890613092 hasConcept C2777982462 @default.
• W2890613092 hasConcept C2779306644 @default.
• W2890613092 hasConcept C2780210213 @default.
• W2890613092 hasConcept C2780323712 @default.
• W2890613092 hasConcept C44249647 @default.
• W2890613092 hasConcept C71924100 @default.
• W2890613092 hasConcept C86803240 @default.
• W2890613092 hasConcept C90924648 @default.
• W2890613092 hasConcept C95190672 @default.
• W2890613092 hasConceptScore W2890613092C121608353 @default.
• W2890613092 hasConceptScore W2890613092C126322002 @default.
• W2890613092 hasConceptScore W2890613092C143998085 @default.
• W2890613092 hasConceptScore W2890613092C146357865 @default.
• W2890613092 hasConceptScore W2890613092C151730666 @default.
• W2890613092 hasConceptScore W2890613092C187960798 @default.

• next